Daan Gene announced that Guangyong Technology, the controlling shareholder of the company, completed the commercial and commercial change registration on August 13, 2026, and the shareholder was changed from Guangzhou Financial Holdings Group to Guangzhou Pharmaceutical Capital. Guangzhou Pharmaceutical Capital holds 100% of Guangyong Technology's shares, then indirectly controls 16.63% of the company's shares and becomes the company's indirect controlling shareholder. The actual controller is still the Guangzhou Municipal People's Government. The transfer of Daan Gene shares in the agreed transfer method still needs to obtain compliance confirmation from the Shenzhen Stock Exchange and go through transfer registration procedures.

Daan Gene announced that Guangyong Technology, the controlling shareholder of the company, completed the commercial and commercial change registration on August 13, 2026, and the shareholder was changed from Guangzhou Financial Holdings Group to Guangzhou Pharmaceutical Capital. Guangzhou Pharmaceutical Capital holds 100% of Guangyong Technology's shares, then indirectly controls 16.63% of the company's shares and becomes the company's indirect controlling shareholder. The actual controller is still the Guangzhou Municipal People's Government. The transfer of Daan Gene shares in the agreed transfer method still needs to obtain compliance confirmation from the Shenzhen Stock Exchange and go through transfer registration procedures.